s-ethyl glutathione has been researched along with warfarin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hollenberg, PF; Kent, UM; Kobayashi, Y; Puppali, SG; Rimoldi, JM; Sridar, C; Waskell, L; Zhang, H | 1 |
Alexova, P; Benes, P; Knopfova, L; Smarda, J; Spanova, A | 1 |
2 other study(ies) available for s-ethyl glutathione and warfarin
Article | Year |
---|---|
Structure-activity relationship and elucidation of the determinant factor(s) responsible for the mechanism-based inactivation of cytochrome P450 2B6 by substituted phenyl diaziridines.
Topics: Aryl Hydrocarbon Hydroxylases; Aziridines; Coumarins; Cytochrome P-450 CYP2B6; Glutathione; In Vitro Techniques; Oxidoreductases, N-Demethylating; Structure-Activity Relationship | 2006 |
Redox state alters anti-cancer effects of wedelolactone.
Topics: Acetylcysteine; Antigens, Neoplasm; Antineoplastic Agents; Breast Neoplasms; Catalase; Cell Line, Tumor; Cell Survival; Coumarins; DNA Topoisomerases, Type II; DNA-Binding Proteins; Female; Glutathione; Humans; Immunoblotting; In Vitro Techniques; Molecular Structure; NAD; Oxidation-Reduction | 2012 |